GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPI, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP3, FABP4, FUT7, HMGCR, HSD17B1, HSD17B2, MET, PPARA, PTGS1, PTGS2 |
10.7018 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FUT7, GLO1, HMGCR, PIM1, PPARA, PTGS1, PTGS2, TYR, XDH |
9.89331 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, APEX1, APP, AXL, BCL2, CA9, CSNK2A1, CXCL8, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP3, HMGCR, HSD17B2, IGF1R, MMP2, MMP9, PPARA, PTGS2, SRC, TYR |
9.54266 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPI, APEX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B1, HSD17B2, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS1, PTGS2, SRC, TOP2A, TYR, XDH |
9.26657 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APEX1, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, MMP9, PTGS2, SRC |
9.15927 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPI, APEX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B1, HSD17B2, HTR1A, IGF1R, KDR, MET, MMP1, MMP2, PIM1, PPARA, PTGS1, PTGS2, SRC, TOP2A, TYR, XDH |
8.66208 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, APEX1, APP, AXL, BCL2, CA2, CA9, CSNK2A1, CXCL8, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP3, FABP4, FLT3, HMGCR, HSD17B2, IGF1R, KDR, MMP2, PPARA, PTGS2, SRC, TYR |
8.66208 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, ALPI, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP3, FABP4, FUT7, HMGCR, MET, PPARA, PTGS1, PTGS2 |
7.79439 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.64984 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, APEX1, APP, AXL, BCL2, CA2, CA9, CSNK2A1, CXCL8, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP3, FABP4, FLT3, HMGCR, HSD17B2, IGF1R, KDR, MMP2, MMP9, PPARA, PTGS2, SRC, TYR |
7.61503 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
7.22981 |
[BP] GO:0042127 |
regulation of cell proliferation
|
AKR1B1, APP, BCL2, CSNK2A1, CXCL8, CYP1B1, DRD2, FABP3, FLT3, HMGCR, HTR1A, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PTGS1, PTGS2, SRC, XDH |
6.91587 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HMGCR, HSD17B1, HSD17B2, PTGS1, PTGS2, TYR, XDH |
6.44509 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
6.43182 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DRD2, FABP3, FABP4, FLT3, HMGCR, HSD17B1, HSD17B2, HTR1A, KDR, MET, PPARA, PTGS1, PTGS2, SRC, XDH |
6.4069 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CA2, CA9, CBR1, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B2, KDR, MET, MMP2, MMP9, PIM1, PPARA, PTGS2, SRC, TOP2A, TYR |
6.4069 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HMGCR, HSD17B1, HSD17B2 |
6.34648 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, GLO1, HMGCR, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTGS2, SRC, TOP2A, XDH |
6.1428 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, APEX1, APP, BCL2, CA2, CA9, CSNK2A1, CXCL8, CYP1A2, FABP3, FLT3, IGF1R, MMP2, PPARA, PTGS2, SRC |
6.00045 |
[BP] GO:0033993 |
response to lipid
|
AXL, BCL2, CA2, CA9, CSNK2A1, CXCL8, CYP1A1, CYP1A2, FABP3, FLT3, HSD17B2, PTGS2, SRC, TYR |
5.86507 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, GLO1, HMGCR, IGF1R, KDR, MET, MMP9, PIM1, PTGS2, SRC, TOP2A, XDH |
5.86507 |
[BP] GO:0014070 |
response to organic cyclic compound
|
APEX1, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, FLT3, PTGS2, SRC, TYR |
5.85016 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
5.51081 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
5.51081 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, DRD2, HMGCR, HTR1A, TYR |
5.46244 |
[BP] GO:0010647 |
positive regulation of cell communication
|
AKR1B1, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, FLT3, HMGCR, KDR, MET, MMP12, MMP9, PTGS2, SRC, XDH |
5.37072 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, HMGCR, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTGS2, SRC |
5.37072 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1B1, DRD2, FABP3, FLT3, HMGCR, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, SRC, TOP2A, XDH |
5.37072 |
[BP] GO:0023056 |
positive regulation of signaling
|
AKR1B1, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, FLT3, HMGCR, KDR, MET, MMP12, MMP9, PTGS2, SRC, XDH |
5.37072 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
5.37072 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, GLO1, HMGCR, IGF1R, KDR, MMP9, PIM1, PTGS2, SRC, TOP2A, XDH |
5.19261 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, APP, AXL, BCL2, CYP1B1, MMP9, PTGS1, PTGS2, SRC |
5.19003 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, HMGCR, IGF1R, KDR, MET, MMP9, PIM1, PTGS2, SRC |
4.98356 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, BCL2, CA9, CYP1A1, CYP1B1, DRD2, FABP3, HMGCR, KDR, PTGS2, SRC |
4.91332 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CSNK2A1, DRD2, FLT3, HMGCR, HTR1A, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PTGS2 |
4.90445 |
[BP] GO:0032501 |
multicellular organismal process
|
AKR1B1, AKR1B10, ALOX5, ALPI, APP, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD2, FABP4, HMGCR, HSD17B2, HTR1A, IGF1R, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, SRC, TYR |
4.8704 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1B1, DRD2, FABP3, FABP4, FLT3, HMGCR, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, SRC, TOP2A, XDH |
4.78903 |
[BP] GO:0030334 |
regulation of cell migration
|
APEX1, APP, BCL2, CXCL8, CYP19A1, CYP1B1, DRD2, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
4.71099 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CA2, CA9, CSNK2A1, CXCL8, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP3, FABP4, FLT3, HMGCR, HSD17B2, HTR1A, IGF1R, KDR, MMP12, MMP2, MMP9, PPARA, PTGS1, PTGS2, SRC, TOP2A, TYR |
4.70525 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, PTGS1, PTGS2 |
4.68305 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, APEX1, AXL, BCL2, CYP1A1, CYP1B1, DRD2, HMGCR, KDR, SRC |
4.65788 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPI, APEX1, APP, AURKB, AXL, BCL2, CBR1, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B1, HSD17B2, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS1, PTGS2, SRC, TOP2A, TYR, XDH |
4.63767 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.6231 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, APEX1, APP, AXL, BCL2, CXCL8, CYP1A1, CYP1A2, CYP1B1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, PTGS2, SRC |
4.6035 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, FABP3, FLT3, PPARA, PTGS2, SRC |
4.6035 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, FABP3, PPARA |
4.54675 |
[BP] GO:2000145 |
regulation of cell motility
|
APEX1, APP, BCL2, CXCL8, CYP19A1, CYP1B1, DRD2, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
4.49166 |
[BP] GO:0010038 |
response to metal ion
|
APP, BCL2, CA2, CYP1A1, CYP1A2, DRD2, FABP4, MMP9, PTGS2 |
4.48186 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALPI, CSNK2A1, CYP19A1, CYP1A1, HMGCR, HSD17B1, HSD17B2, PTGS1, PTGS2 |
4.44978 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, APEX1, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CXCL8, CYP19A1, CYP1B1, DRD2, HMGCR, HTR1A, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTGS2, SRC |
4.44978 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
4.39848 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, FLT3, HSD17B2, KDR, PPARA, SRC, TYR |
4.34731 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, HMGCR, IGF1R, KDR, MMP9, PIM1, PTGS2, SRC |
4.34731 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, APEX1, APP, AXL, BCL2, CXCL8, CYP1A1, CYP1B1, FABP4, FLT3, IGF1R, KDR, MMP2, PTGS2, SRC |
4.22106 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
4.22106 |
[BP] GO:0040012 |
regulation of locomotion
|
APEX1, APP, BCL2, CXCL8, CYP19A1, CYP1B1, DRD2, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
4.16016 |
[BP] GO:0051270 |
regulation of cellular component movement
|
APEX1, APP, BCL2, CXCL8, CYP19A1, CYP1B1, DRD2, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
4.14951 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, MMP9, SRC |
4.09989 |
[BP] GO:0032787 |
None
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, PPARA, PTGS1, PTGS2 |
4.08956 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, SRC |
4.06916 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 |
4.06916 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
4.06916 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, APP, DRD2, FABP3, FLT3, IGF1R, MMP2, PPARA, PTGS2, SRC, TYR |
4.06884 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPI, APEX1, APP, AURKB, AXL, BCL2, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS1, PTGS2, SRC, TOP2A, TYR, XDH |
4.01004 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
4.00293 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 |
3.97522 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, AKR1B1, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CXCL8, CYP19A1, CYP1B1, DRD2, FLT3, HMGCR, HTR1A, IGF1R, KDR, MET, MMP12, MMP9, PTGS2, SRC, XDH |
3.95375 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, DRD2, HMGCR, HSD17B1, HSD17B2, HTR1A |
3.9078 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CA2, CA9, CXCL8, CYP1A1, CYP1A2, CYP1B1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, PTGS2, SRC, TOP2A |
3.88673 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, AKR1B1, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CXCL8, CYP19A1, CYP1B1, DRD2, FLT3, HMGCR, HTR1A, IGF1R, KDR, MET, MMP12, MMP9, PTGS2, SRC, XDH |
3.88673 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
AKR1B1, APP, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, FLT3, HMGCR, KDR, MET, MMP12, MMP9, PTGS2, SRC, XDH |
3.88673 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
3.85533 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
AKR1B1, APP, AXL, BCL2, CSNK2A1, CXCL8, CYP1B1, DRD2, FABP4, FLT3, HMGCR, KDR, MET, MMP12, MMP2, MMP9, PTGS2, SRC, XDH |
3.85417 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
AKR1B1, APP, AXL, BCL2, CYP1B1, DRD2, FLT3, HMGCR, KDR, MET, PTGS2, SRC, XDH |
3.83125 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPI, APEX1, APP, AURKB, AXL, BCL2, CSNK2A1, DRD2, FLT3, HMGCR, IGF1R, KDR, MET, PIM1, PTGS2, SRC, XDH |
3.82798 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, APP, DRD2, FABP3, FLT3, IGF1R, MMP2, PPARA, PTGS2, SRC, TYR |
3.79664 |
[BP] GO:0044092 |
negative regulation of molecular function
|
APP, AURKB, CSNK2A1, CYP1B1, DRD2, FABP4, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, SRC |
3.77461 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPI, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1A1, CYP1A2, DRD2, FLT3, FUT7, GLO1, HMGCR, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, SRC, TOP2A, TYR, XDH |
3.7629 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC |
3.75574 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, GLO1, HMGCR |
3.73832 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, DRD2, HMGCR, MMP2, PPARA, PTGS2, SRC, TYR |
3.7287 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, FABP3, PPARA |
3.72106 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, PIM1, PPARA, PTGS1, PTGS2, TYR |
3.62023 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
AKR1B1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, FLT3, HMGCR, IGF1R, KDR, MET, MMP9, PTGS2, SRC, XDH |
3.61044 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPI, APEX1, APP, AURKB, AXL, BCL2, CSNK2A1, DRD2, FLT3, HMGCR, IGF1R, KDR, MET, PIM1, PTGS2, SRC, XDH |
3.57829 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AKR1B10, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
3.56891 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, HMGCR, MMP2, MMP9, PTGS2 |
3.55732 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, CXCL8, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
3.53906 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD2, HTR1A, TYR |
3.50901 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.45166 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, CXCL8, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
3.42759 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CSNK2A1, CXCL8, CYP19A1, CYP1B1, DRD2, FABP3, FABP4, GLO1, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, PTGS2, SRC, TOP2A, XDH |
3.39058 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, APP, AXL, CXCL8, CYP1B1, IGF1R, MMP2, MMP9, PTGS2, SRC |
3.36759 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, CXCL8, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
3.33928 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, APP, FABP3, IGF1R, PPARA, PTGS2, SRC |
3.3368 |
[BP] GO:0019371 |
None
|
CBR1, PTGS1, PTGS2 |
3.3368 |
[BP] GO:0032844 |
regulation of homeostatic process
|
AURKB, BCL2, CA2, CA7, DRD2, HMGCR, KDR, PTGS2, SRC |
3.32032 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, PIM1, PPARA, PTGS1, PTGS2, TYR |
3.23619 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, CXCL8, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
3.23538 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, APP, AXL, BCL2, CA2, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, FLT3, HSD17B2, KDR, MMP9, PIM1, PPARA, PTGS2, SRC, TYR |
3.21289 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, AXL, BCL2, CA2, CXCL8, CYP1B1, DRD2, HMGCR, KDR, MET, MMP12, MMP9, PIM1, PTGS2, SRC |
3.19891 |
[BP] GO:0006950 |
response to stress
|
ACHE, AKR1B1, APEX1, APP, AXL, BCL2, CA2, CA9, CXCL8, CYP1A1, CYP1A2, CYP1B1, DRD2, HTR1A, MMP2, MMP9, PPARA, PTGS1, PTGS2, SRC, TOP2A |
3.19664 |
[BP] GO:0001666 |
response to hypoxia
|
BCL2, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SRC |
3.18066 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, PIM1, PPARA, PTGS1, PTGS2, TYR |
3.17787 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
3.13818 |
[BP] GO:0042592 |
homeostatic process
|
AKR1B1, APEX1, APP, AXL, BCL2, CA12, CA2, CA7, DRD2, FABP3, FABP4, FLT3, MET, SRC |
3.11368 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
BCL2, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SRC |
3.11368 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CYP1A1, FLT3, HTR1A, MET, PIM1, SRC, TYR |
3.11368 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD2, HMGCR, IGF1R, MET, MMP9, PTGS2, SRC, XDH |
3.07248 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD2, HTR1A |
2.99012 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, KDR, PTGS2, SRC |
2.9777 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, PPARA, SRC, TOP2A |
2.96078 |
[BP] GO:0009416 |
response to light stimulus
|
APP, AURKB, BCL2, DRD2, HMGCR, PTGS2, TYR |
2.95392 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.94851 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.91485 |
[BP] GO:0070482 |
response to oxygen levels
|
BCL2, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SRC |
2.90713 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
2.85609 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, APP, AXL, BCL2, CBR1, CYP1A1, DRD2, FABP4, FLT3, FUT7, GLO1, HMGCR, KDR, MET, MMP2, MMP9, PTGS2, SRC, TOP2A |
2.78686 |
[BP] GO:0030198 |
extracellular matrix organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.75585 |
[BP] GO:0043062 |
extracellular structure organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.74967 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR |
2.71987 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
APP, CA2, CA7, DRD2, PTGS2 |
2.70527 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
BCL2, CA2, CA7, DRD2, KDR, SRC |
2.70145 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.68413 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, PTGS2, SRC |
2.67933 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, FABP3, HSD17B2, KDR, MMP2, PTGS2, SRC |
2.6538 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, HMGCR |
2.6538 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC |
2.6538 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HMGCR, HSD17B1, HSD17B2 |
2.63982 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.62927 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2 |
2.62927 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, HMGCR, MMP2, MMP9, PTGS2 |
2.61494 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, SRC |
2.61399 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.59552 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.58115 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.58115 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.538 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CSNK2A1, CXCL8, CYP19A1, CYP1B1, DRD2, FABP3, FABP4, GLO1, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, PTGS2, SRC, TOP2A, XDH |
2.538 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
CXCL8, CYP19A1, DRD2, FABP4, HMGCR, KDR, MET, MMP12, PPARA, PTGS2 |
2.53059 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC |
2.51266 |
[BP] GO:0007568 |
aging
|
APEX1, AURKB, BCL2, CYP1A1, HMGCR, PTGS2 |
2.493 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.47559 |
[BP] GO:0051726 |
regulation of cell cycle
|
APEX1, APP, AURKB, BCL2, CSNK2A1, CXCL8, CYP1A1, DRD2, PIM1, PTGS2, SRC, TOP2A |
2.47559 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
APEX1, APP, CYP1A1, CYP1B1, FLT3, PTGS2, SRC |
2.45882 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.42682 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, SRC |
2.38231 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
CYP1A1, FABP3, FLT3, HMGCR, PPARA, PTGS2, SRC |
2.37818 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.36875 |
[BP] GO:0071248 |
cellular response to metal ion
|
CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
2.36255 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, APP, AXL, BCL2, CA2, CA7, CYP19A1, DRD2, HMGCR, HTR1A, MMP12, MMP9, PPARA, PTGS2, SRC |
2.36255 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.34335 |
[BP] GO:0016477 |
cell migration
|
AXL, CXCL8, CYP1B1, DRD2, FUT7, KDR, MMP1, MMP12, MMP9, SRC |
2.33035 |
[BP] GO:0040011 |
locomotion
|
AXL, CXCL8, CYP1B1, DRD2, FUT7, KDR, MET, MMP1, MMP12, MMP9, SRC |
2.31076 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.24846 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APEX1, APP, CXCL8, FLT3, IGF1R, MMP2, PTGS2, SRC |
2.24846 |
[BP] GO:0002521 |
leukocyte differentiation
|
AXL, BCL2, FLT3, FUT7, GLO1, MMP9 |
2.23807 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, CBR1, CYP1A1, CYP1A2, CYP1B1, DRD2 |
2.23754 |
[BP] GO:0080134 |
regulation of response to stress
|
APP, CYP19A1, DRD2, FABP4, HMGCR, IGF1R, MET, MMP12, MMP2, PPARA, PTGS2, SRC, XDH |
2.22058 |
[BP] GO:0032963 |
collagen metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.21697 |
[BP] GO:0048583 |
regulation of response to stimulus
|
AKR1B1, APP, AURKB, AXL, BCL2, CSNK2A1, CXCL8, CYP19A1, CYP1B1, DRD2, FABP4, FLT3, HMGCR, IGF1R, KDR, MET, MMP12, MMP2, MMP9, PPARA, PTGS2, SRC, XDH |
2.19378 |
[BP] GO:0051094 |
positive regulation of developmental process
|
APP, AXL, BCL2, CA2, CXCL8, CYP1B1, DRD2, HMGCR, KDR, PIM1, PTGS2, SRC |
2.18789 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, APP, IGF1R, MMP2, PTGS2, SRC |
2.18122 |
[BP] GO:1901661 |
None
|
AKR1B1, AKR1B10, HMGCR |
2.17679 |
[BP] GO:0016042 |
lipid catabolic process
|
AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.17679 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, FLT3, IGF1R, KDR, MET, SRC, TOP2A |
2.17679 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
BCL2, CXCL8, CYP19A1, DRD2, HMGCR, IGF1R, MET, MMP12, MMP9, PPARA, PTGS2, SRC, XDH |
2.16573 |
[BP] GO:0045744 |
None
|
CXCL8, DRD2, MET |
2.14185 |
[BP] GO:0010039 |
response to iron ion
|
BCL2, CYP1A1, DRD2 |
2.14185 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.13958 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, BCL2, CXCL8, DRD2, HMGCR, IGF1R, MET, MMP12, MMP9, PTGS2, SRC, XDH |
2.13958 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALPI, CSNK2A1, DRD2, FABP3, FABP4, MET |
2.13958 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
AXL, CXCL8, CYP1A1, CYP1A2, PTGS2, SRC |
2.13212 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, BCL2, CXCL8, DRD2, HMGCR, IGF1R, MET, MMP12, MMP9, PTGS2, SRC, XDH |
2.13212 |
[BP] GO:0042325 |
regulation of phosphorylation
|
APP, BCL2, DRD2, FABP4, FLT3, HMGCR, IGF1R, KDR, MMP9, PPARA, PTGS2, SRC, XDH |
2.12937 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
CA2, CA7, DRD2 |
2.11496 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
APP, BCL2, DRD2, FABP3, FABP4, FLT3, HMGCR, IGF1R, KDR, MMP9, PPARA, PTGS2, SRC, XDH |
2.11468 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
2.11259 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
APP, BCL2, DRD2, FABP3, FABP4, FLT3, HMGCR, IGF1R, KDR, MMP9, PPARA, PTGS2, SRC, XDH |
2.08458 |
[BP] GO:0043154 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, MMP9, PTGS2, SRC |
2.08458 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
APP, BCL2, DRD2, FABP3, FLT3, HMGCR, KDR, MMP9, PTGS2, SRC, XDH |
2.08458 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
APP, BCL2, DRD2, FABP3, FLT3, HMGCR, KDR, MMP9, PTGS2, SRC, XDH |
2.08458 |
[BP] GO:0048870 |
cell motility
|
AXL, CXCL8, CYP1B1, DRD2, FUT7, KDR, MMP1, MMP12, MMP9, SRC |
2.05186 |
[BP] GO:0009314 |
response to radiation
|
APP, AURKB, BCL2, DRD2, HMGCR, PTGS2, TYR |
2.04625 |
[BP] GO:0009611 |
response to wounding
|
ACHE, BCL2, CYP1A1, DRD2, PPARA |
2.04517 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.0236 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APEX1, APP, IGF1R, MMP2, PTGS2, SRC |
2.01609 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, MMP9, PTGS2, SRC |
2.00914 |
[BP] GO:0009987 |
cellular process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPI, APEX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B1, HSD17B2, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS1, PTGS2, SRC, TOP2A, TYR, XDH |
2.00914 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
AXL, CXCL8, CYP1A1, CYP1A2, PTGS2, SRC |
2.00914 |
[CC] GO:0005783 |
None
|
APEX1, APP, BCL2, CA4, CYP19A1, FLT3, HMGCR, KDR, PTGS2, XDH |
1.98113 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, AKR1B1, AKR1B10, ALOX5, APEX1, APP, AURKB, BCL2, CA1, CA2, CA4, CA7, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B1, HSD17B2, KDR, MMP2, MMP9, PIM1, PTGS1, PTGS2, SRC, TOP2A, TYR, XDH |
1.86085 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP |
1.83779 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FLT3, HMGCR, HSD17B2, PTGS1, PTGS2 |
1.61484 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HMGCR, HSD17B2, PTGS1, PTGS2 |
1.49613 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, ALPI, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, GLO1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, TYR, XDH |
10.7018 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
10.7018 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPI, APEX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP3, FABP4, FLT3, GLO1, HMGCR, HSD17B1, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS1, PTGS2, SRC, TOP2A, TYR, XDH |
10.4002 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPI, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FLT3, FUT7, GLO1, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PTGS1, PTGS2, SRC, TOP2A, TYR, XDH |
10.0082 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.64984 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HMGCR, HSD17B1, HSD17B2, PTGS1, PTGS2, TYR, XDH |
7.64984 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.01422 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPI, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, GLO1, HTR1A, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS1, PTGS2, TOP2A, TYR, XDH |
6.35483 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, GLO1 |
6.1819 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2, SRC |
4.81397 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPI, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, GLO1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS1, PTGS2, TOP2A, TYR, XDH |
4.68305 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, CBR1, HMGCR, HSD17B1, HSD17B2, XDH |
4.68305 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2, SRC |
4.65788 |
[MF] GO:0008270 |
zinc ion binding
|
ALPI, CA1, CA12, CA2, CA4, CA7, CA9, GLO1, MMP1, MMP12, MMP2, MMP9, PPARA |
4.55119 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2, TYR |
4.39848 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, HMGCR, HSD17B1, PTGS1, PTGS2, SRC, XDH |
4.06916 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
4.06884 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.90246 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.88673 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, CBR1, HMGCR, HSD17B1, HSD17B2 |
3.88673 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, FLT3, IGF1R, KDR, MET, PIM1, PPARA, SRC, TOP2A |
3.87313 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.48537 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH |
3.25506 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
3.15037 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.08316 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.99746 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
2.99596 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, APP, BCL2, CSNK2A1, DRD2, FLT3, HMGCR, IGF1R, KDR, MET, MMP9, PTGS2, TOP2A, TYR, XDH |
2.94816 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, APEX1, CSNK2A1, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, SRC |
2.43252 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, SRC |
2.37843 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.0236 |